News Alert: Pfizer’s covid-19 pill sharply reduced hospitalizations and deaths and appears to work against omicron variant, company reports
| The worst outcomes from infection were reduced by nearly 90 percent among high-risk patients, the company data showed. The Pfizer pill could become available within weeks, a crucial development as many versions of a mainstay of covid treatment, monoclonal antibodies, may not be effective against the omicron variant. |
 |
| | | | News Alert | Dec. 14, 7:09 a.m. EST | | | | | The worst outcomes from infection were reduced by nearly 90 percent among high-risk patients, the company data showed. The Pfizer pill could become available within weeks, a crucial development as many versions of a mainstay of covid treatment, monoclonal antibodies, may not be effective against the omicron variant. | | | | | |
| |
